17β hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma

OBJECTIVE: 17β-hydroxysteroid dehydrogenase isoform 12 (HSD17B12) overexpression is associated with poor clinical outcome in invasive ductal carcinoma of the breast. Here, we evaluated HSD17B12 overexpression and its activity in ovarian carcinoma (OvCa) to determine its role in growth and progressio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Szajnik, Marta, Szczepanski, Miroslaw J., Elishaev, Esther, Visus, Carmen, Lenzner, Diana, Zabel, Maciej, Glura, Marta, DeLeo, Albert B., Whiteside, Theresa L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3607433/
https://ncbi.nlm.nih.gov/pubmed/22903146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2012.08.010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados